Skip to main content
Clinical Trials/NCT05521607
NCT05521607RecruitingNot Applicable

Evaluation of a Smartphone-based Screening Tool (Picterus JP) for Neonatal Jaundice in Newborns with High Melanin Content (Chicago)

Picterus AS1 site in 1 country250 target enrollmentStarted: January 6, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
250
Locations
1
Primary Endpoint
Enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.

Study Overview

Brief Summary

A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) to enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.

Detailed Description

A cross-sectional conductive study at the University of Chicago Medicine facilities (hospital and outreach clinics) will be conducted to include a total of 250 newborns with a desired distribution of skin color according to Neomar's scale : skin color 1 and 2: 20%, skin color 3: 30% and skin color 4: 50%. Skin color may also be quantitatively assessed using a handheld spectrophotometer (CM-700d, Konica Minolta).

The Picterus Calibration Card will be placed on the chest of the newborn with the hole in the card placed over the infant's chest. A validated smartphone with Picterus JP will be used to collect digital images, which are analysed to calculate a Picterus bilirubin value.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
1 Day to 14 Days (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Infants born with gestational age > 35 weeks.
  • •Birth weight ≥ 1800 grams
  • •Age 1 - 14 days
  • •Infants requiring a TSB blood sample for clinically suspected jaundice as part of standard care

Exclusion Criteria

  • •Infants showing signs of inborn disease.
  • •Infants with skin rash or other skin disease that affects the skin where measurements are performed.
  • •Infants transferred to the pediatric ward for medical treatment.
  • •Infants that have received phototherapy in the last 24 hours

Arms & Interventions

Enable high qualitative estimation of bilirubin levels in the blood of new-borns

Other

There is only one arm in this study which is to enable high qualitative estimation of bilirubin levels in the blood of new-borns, independent of skin color, using Picterus JP.

Intervention: Picterus Jaundice Pro (JP) (Device)

Outcomes

Primary Outcomes

Enable high qualitative estimation of bilirubin levels in the blood of newborns, independent of skin color, using Picterus JP.

Time Frame: 3-6 months

Evaluate of smartphone-based screening tool (Picterus JP) for neonatal jaundice in newborns with high melanin content.

Secondary Outcomes

  • Correlate estimates of bilirubin levels obtained by Picterus JP with TSB, TcB and VA in newborns with high melanin content in the skin.(3-6 months)
  • Determine the accuracy of Picterus JP in newborns with high melanin content in the skin.(3-6 months)
  • Adapt the current algorithm of Picterus JP to newborns with high melanin content in the skin.(3-6months)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials